Skip to main content
. Author manuscript; available in PMC: 2010 Feb 22.
Published in final edited form as: Neurobiol Aging. 2007 Sep 21;30(4):607–614. doi: 10.1016/j.neurobiolaging.2007.08.003

Table 2b.

Odds of developing cognitive impairment (unadjusted and multivariate adjusted for age, education and baseline cognition) over 4 years by ESR1 and ESR2 single nucleotide polymorphism genotype in men.

ESR1 SNP
Genotype
N With
Genotype
%
Impaired
Unadjusted
OR (95% CI)
Multivariate
adjusted OR
(95% CI)
ESR2 SNP
Genotype
N With
Genotype
%
Impaired
Unadjusted
OR (95% CI)
Multivariate
adjusted OR
(95% CI)
rs8179176 rs1255998
GG 115 18 0.74 (0.45-1.21) 0.77 (0.45-1.32) GG 110 35 1.96 (1.29-3.00) 1.68 (1.06-
2.65)
AA or AG 1034 23 1.0 (ref) 1.0 (ref) CC or CG 1039 21 1.0 (ref) 1.0 (ref)

rs9340799 rs1256065
GG 245 23 1.03 (0.73-1.44) 1.00 (0.71-1.41) CC 139 26 1.23 (0.82-1.85) 1.36 (0.88-
2.10)
AA or AG 899 22 1.0 (ref) 1.0 (ref) AA or AC 997 22 1.0 (ref) 1.0 (ref)

rs3728524 rs1256049
GG or GA 171 32 1.79 (1.25-2.57) 1.54 (1.07-2.23) AA or AG 122 25 1.21 (0.78-1.86) 1.11 (0.71-
1.75)
AA 977 20 1.0 (ref) 1.0 (ref) GG 1044 22 1.0 (ref) 1.0 (ref)

rs3798577 rs1256030
CC 249 20 0.87 (0.61-1.23) 0.82 (0.57-1.18) TT 169 28 1.48 (1.02-2.14) 1.56 (1.07-
2.29)
TT or TC 889 23 1.0 (ref) 1.0 (ref) CC or CT 971 21 1.0 (ref) 1.0 (ref)

Most common allele frequencies: ESR1 rs8179176 A=67%, rs9340799 A=52%, rs728524 A=91%, rs3798577 T=54%; ESR2 rs1255998 C=74%, rs1256065 A=68%, rs1256049 G=95%, rs1256030 C=62%.